Anna Vossenkämper

2.8k total citations
28 papers, 1.2k citations indexed

About

Anna Vossenkämper is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Anna Vossenkämper has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Anna Vossenkämper's work include Immune Cell Function and Interaction (9 papers), Inflammatory Bowel Disease (6 papers) and T-cell and B-cell Immunology (5 papers). Anna Vossenkämper is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Inflammatory Bowel Disease (6 papers) and T-cell and B-cell Immunology (5 papers). Anna Vossenkämper collaborates with scholars based in United Kingdom, United States and Germany. Anna Vossenkämper's co-authors include Thomas T. MacDonald, Jo Spencer, Andrew J. Stagg, Gary Warnes, Enno Klußmann, Pavel I. Nedvetsky, Burkhard Wiesner, Walter Rosenthal, Olivier Marchès and Theodore J. Sanders and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Gastroenterology.

In The Last Decade

Anna Vossenkämper

28 papers receiving 1.2k citations

Peers

Anna Vossenkämper
Tracy L. Burcin United States
Michail Schizas United States
Marguerite S. Buzza United States
Omid Rasool Sweden
Ning Go United States
Debra A. Long Priel United States
Long Huang China
Shai Cohen Israel
Stefanie Derer Germany
Karin R. Engelhardt United Kingdom
Tracy L. Burcin United States
Anna Vossenkämper
Citations per year, relative to Anna Vossenkämper Anna Vossenkämper (= 1×) peers Tracy L. Burcin

Countries citing papers authored by Anna Vossenkämper

Since Specialization
Citations

This map shows the geographic impact of Anna Vossenkämper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vossenkämper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vossenkämper more than expected).

Fields of papers citing papers by Anna Vossenkämper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Vossenkämper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vossenkämper. The network helps show where Anna Vossenkämper may publish in the future.

Co-authorship network of co-authors of Anna Vossenkämper

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Vossenkämper. A scholar is included among the top collaborators of Anna Vossenkämper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Vossenkämper. Anna Vossenkämper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, Kevin J., Luana Maggiore, Simon Clare, et al.. (2021). Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease. Scientific Reports. 11(1). 19422–19422. 23 indexed citations
2.
Borghesan, Michela, Juan Fafián‐Labora, Olga Eleftheriadou, et al.. (2019). Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3. Cell Reports. 27(13). 3956–3971.e6. 205 indexed citations
3.
Pararasa, Chathyan, Na Zhang, Thomas J Tull, et al.. (2019). Reduced CD27−IgD− B Cells in Blood and Raised CD27−IgD− B Cells in Gut-Associated Lymphoid Tissue in Inflammatory Bowel Disease. Frontiers in Immunology. 10. 361–361. 31 indexed citations
4.
Bergamaschi, Daniele, et al.. (2019). Simultaneous polychromatic flow cytometric detection of multiple forms of regulated cell death. APOPTOSIS. 24(5-6). 453–464. 19 indexed citations
5.
Barry, Sayka, Ezra Aksoy, Anna Vossenkämper, et al.. (2019). Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation. Cell Reports. 27(5). 1461–1471.e4. 21 indexed citations
6.
Xie, Qing, Xin Zeng, Wensheng Xie, et al.. (2019). Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease. PLoS ONE. 14(4). e0215033–e0215033. 25 indexed citations
7.
Crowe, Jenny, Kevin J. Roberts, Luana Maggiore, et al.. (2018). Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease. Scientific Reports. 8(1). 4941–4941. 48 indexed citations
8.
Díaz-Jiménez, David, Lucía Núñez, Marjorie De la Fuente, et al.. (2017). A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis. Scientific Reports. 7(1). 10180–10180. 9 indexed citations
9.
Pike, Robert N., et al.. (2017). Simultaneous flow cytometric immunophenotyping of necroptosis, apoptosis and RIP1-dependent apoptosis. Methods. 134-135. 56–66. 25 indexed citations
10.
Biancheri, Paolo, Randall J. Brezski, Antonio Di Sabatino, et al.. (2015). Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients With Inflammatory Bowel Disease. Gastroenterology. 149(6). 1564–1574.e3. 104 indexed citations
11.
Powell, Nick, Jonathan W. Lo, Paolo Biancheri, et al.. (2015). Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation. Gastroenterology. 149(2). 456–467.e15. 67 indexed citations
12.
Vossenkämper, Anna, Christian Hundsrucker, Kevin Page, et al.. (2014). A CD3-Specific Antibody Reduces Cytokine Production and Alters Phosphoprotein Profiles in Intestinal Tissues From Patients With Inflammatory Bowel Disease. Gastroenterology. 147(1). 172–183. 28 indexed citations
13.
Vossenkämper, Anna, Niloufar Safinia, Theodore J. Sanders, et al.. (2013). A role for gut-associated lymphoid tissue in shaping the human B cell repertoire. The Journal of Experimental Medicine. 210(9). 1665–1674. 68 indexed citations
14.
McCarthy, Neil E., Charlotte Hedin, Anna Vossenkämper, et al.. (2012). OC-009 Human anti-microbial vδ2+ t-cells are novel intestinal lymphocytes with functional relevance in crohn's disease. Gut. 61(Suppl 2). A4.1–A4. 1 indexed citations
15.
Vossenkämper, Anna, Thomas T. MacDonald, & Olivier Marchès. (2011). Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system. Journal of Inflammation. 8(1). 11–11. 19 indexed citations
16.
Vossenkämper, Anna & Jo Spencer. (2011). Transitional B Cells: How Well Are the Checkpoints for Specificity Understood?. Archivum Immunologiae et Therapiae Experimentalis. 59(5). 379–384. 12 indexed citations
17.
Tzartos, John S., Gulfaraz Khan, Anna Vossenkämper, et al.. (2011). Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology. 78(1). 15–23. 109 indexed citations
18.
Barone, Francesca, Anna Vossenkämper, Laurent Boursier, et al.. (2010). IgA-Producing Plasma Cells Originate From Germinal Centers That Are Induced by B-Cell Receptor Engagement in Humans. Gastroenterology. 140(3). 947–956. 52 indexed citations
19.
Vossenkämper, Anna, Olivier Marchès, Peter D. Fairclough, et al.. (2010). Inhibition of NF-κB Signaling in Human Dendritic Cells by the Enteropathogenic Escherichia coli Effector Protein NleE. The Journal of Immunology. 185(7). 4118–4127. 65 indexed citations
20.
Vossenkämper, Anna, Cosme Alvarado‐Esquivel, Kiyoshi Takeda, et al.. (2004). Both IL‐12 and IL‐18 contribute to small intestinal Th1‐type immunopathology following oral infection with Toxoplasma gondii, but IL‐12 is dominant over IL‐18 in parasite control. European Journal of Immunology. 34(11). 3197–3207. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracy L. Burcin Breakdown of academic impact, for papers by Michail Schizas Breakdown of academic impact, for papers by Marguerite S. Buzza Breakdown of academic impact, for papers by Omid Rasool Breakdown of academic impact, for papers by Ning Go Breakdown of academic impact, for papers by Debra A. Long Priel Breakdown of academic impact, for papers by Long Huang Breakdown of academic impact, for papers by Shai Cohen Breakdown of academic impact, for papers by Stefanie Derer Breakdown of academic impact, for papers by Karin R. Engelhardt
Rankless by CCL
2026